Recombinant tissue-type plasminogen activator (rt-PA) is indicated for the treatment of acute myocardial infarction as a dose of up to 100 mg. Several clinical trials have suggested that higher patency rates can be achieved with a rapid drug administration. A study was conducted in rabbits to determ
Nonlinear pharmacokinetics of tissue-type plasminogen activator in three animal species: a comparison of mathematical models
โ Scribed by Keith R. Godfrey; Paul Tanswell; Ronald A. Bates; Michael J. Chappell; Francis N. Madden
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 241 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0142-2782
No coin nor oath required. For personal study only.
โฆ Synopsis
A recent study presented plasma concentrations of tissue-type plasminogen activator in three different animal species and at several different dose levels. A three-compartment mammillary model with capacity-limited elimination (of Michaelis -Menten form) was postulated to describe the data.
In the present study, several alternative model structures are examined with the view of determining whether better fits can be obtained, whether linear models are significantly worse than nonlinear models, and whether all three compartments are really necessary.
๐ SIMILAR VOLUMES